Sign in

Steven Kahn

@sekahn.bsky.social
407 followers 17 following 17 posts

Physician-scientist interested in diabetes. Opinions are my own.

PostsRepliesMedia
Steven Kahn @sekahn.bsky.social · 17/07/2026
American Diabetes Association (ADA) blocks the publication of opinion pieces in Diabetes Care about the organization and its behavior. Absolute censorship. The editors of Diabetes Care will ensure the truth is known. Are they teaching the government how to behave? What can we expect next from ADA?
zenodo.org
Community Voices: On the Events of the American Diabetes Association 86th Scientific Sessions
The editorial and the seven opinion articles posted here were scheduled for publication on July 13, 2026, in the journal, Diabetes Care. All articles were provided, in advance of the scheduled publica...
32815
Steven Kahn @sekahn.bsky.social · 25/06/2026
Has anyone heard from the AAMC (Association of American Medical Colleges) on biomedical research funding? They represent 176 medical schools in the US and Canada, >490 academic health systems and teaching hospitals, and 70+ academic societies. Despite strength in numbers, they too remain petrified.
0115
Steven Kahn @sekahn.bsky.social · 25/06/2026
Given recent events at the ADA meeting, Kamran Abbasi, editor-in-chief of The British Medical Journal, speaks out on freedom of the press, politics, and science. Why do US editors not do likewise? Where are the medical associations? Muzzled? Do you want to be counted amongst those who stayed silent?
1206
Reposted by Steven Kahn
Jenna Norton @jenna-m-norton.bsky.social · 19/06/2026
Yesterday, I met Jay Bhattacharya briefly for the first time. I don’t think he’s a fan. 😬🤷‍♀️😇 He spoke yesterday at an NIH workshop on Health Disparities. I want to reflect on his talk, as well as the brief interaction that followed. Here goes… 🧵1/???
12407121
Steven Kahn @sekahn.bsky.social · 15/06/2026
Kudos to this Seattle teacher taking the vital message of the need for research funding to her high school students and colleagues. Simply appalling that mere mention of DEI should mean cancellation of funds to educate our youth. Let’s hope more of our great educators can carry her message forward.
0247
Reposted by Steven Kahn
Mark Huising @huisinglab.bsky.social · 12/06/2026
The ADA CEO issues an apology on twitter (receiving 3 likes from 28k followers) for completely mishandling events at recent ADA meeting where @sekahn.bsky.social was ejected, it's bluesky account has 0 posts. Post the apology on bluesky @amdiabetesassn.bsky.social , that's where you audience is!!
2268
Reposted by Steven Kahn
Kristen Boyle, PhD @kristenboyle.bsky.social · 12/06/2026
This past week of science has been like drinking from a firehose. From grant deadlines to OMB, from the ADA and @sekahn.bsky.social to screwworms… Here’s an essay from my perspective. 🧪 #AcademicSky #ScienceCommunication
kristenboylephd.com
All at once: this past week in science
Moments of progress in a firehose of upheaval I haven’t posted in a while. Things have been…busy. And unprecedented. And a little overwhelming. At the start of last week, I thought I might open thi…
1165
Steven Kahn @sekahn.bsky.social · 11/06/2026
These two former chairs of the Board of Directors of the American Diabetes Association encapsulate well the response of many to the "apology" from the ADA. Who is advising them? They cannot seem to get out of their own way.
1125
Steven Kahn @sekahn.bsky.social · 10/06/2026
The ADA apologizes and says it is committed to biomedical research. I expect them and other non-profits to no longer hide behind 501(c)(3) status and to speak out vociferously in public about the destruction being wreaked upon US research, not just NIH. www.youtube.com/watch?v=W7K2...
youtube.com
Statement from The American Diabetes Association Regarding 2026 Scientific Sessions
YouTube video by American Diabetes Association
45226
Steven Kahn @sekahn.bsky.social · 10/06/2026
Thanks for the principled stand by past Principal Officers of the American Diabetes Association. Hopefully, this letter will get the current leadership to reach out in an appropriate manner and set the record straight. They owe it to everyone, and particularly to people with diabetes.
13311
Steven Kahn @sekahn.bsky.social · 10/06/2026
Another piece on the debacle by the American Diabetes Association (ADA). It includes a quote, that the ADA “effectively disregarded my First Amendment rights.” We need to fight for the right to speak freely, in all public forums, including scientific meetings! www.the-scientist.com/police-remov...
urldefense.com
Police Removed Prominent Scientists from the ADA Meeting. Researchers Respond | The Scientist
The organizers of the American Diabetes Association meeting had a group of researchers removed from the event for sharing an editorial about negative impacts of policy changes to research funding.
2138
Steven Kahn @sekahn.bsky.social · 08/06/2026
This just out in Diabetes Care. The need to highlight the destructive plans of the administration continues. Everyone needs to post comments to the OMB website. Relevant links in the article. Don’t delay!! diabetesjournals.org/care/article...
diabetesjournals.org
Please Tell Me It Is Only a Nightmare—The Proposed Dismantling of the United States Federal Research Infrastructure
Steven E. Kahn, Cheryl A.M. Anderson, John B. Buse, Elizabeth Selvin, Vanita R. Aroda, Seth A. Berkowitz, Matthew J. Crowley, Stephanie L. Fitzpatrick, Meg
03928
Steven Kahn @sekahn.bsky.social · 06/06/2026
I grew up in apartheid S Africa, where muzzling of speech and encroachment on academic freedom were the norm. I came to the USA to pursue a career in science. I never thought that at this stage of my career, I would ever experience my youth again. #StandUpForScience #ADA #ADA2026
711738
Steven Kahn @sekahn.bsky.social · 25/04/2025
054
Steven Kahn @sekahn.bsky.social · 04/12/2024
The American Diabetes Association issues an important statement on compounded injectable weight loss medications. diabetesjournals.org/care/article...
diabetesjournals.org
Compounded GLP 1 and Dual GIP/GLP 1 Receptor Agonists: A Statement from the American Diabetes Association
The use of glucagon-like peptide 1 receptor agonist (GLP-1 RA) and dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 RA (GIP/GLP-1 RA) clas
031